Ida Sofie Jensen introduces the strong fundamentals underpinning the Danish innovative life sciences industry, including governmental support for early access to medicines, a collaborative approach to pricing and reimbursement, a highly centralised hospital system, and excellent digitalised patient records. Jensen highlights that thanks to these fundamentals, Denmark is home to the highest number of clinical trials per capita in Europe and will continue to prioritise the industry for the foreseeable future.
Unlike some other countries, where quality data is locked in specific hospitals, we have excellent data across the country and a central personal register, which is crucial
